Product Description:
This topical product for the treatment and prevention of mild and moderate acne has a keratolytic and seboregulatory action while preventing the formation of pustules and local inflammations.
It facilitates the elimination of comedowns (blackheads and whiteheads) and the toilet of the sebaceous follicles.
Cosmetic gel formulation potentiated by the combination of azelaic acid, a new-generation retinoid (HPR) & α-hydroxy acids.
Thanks to their keratolytic, bacteriostatic and sebum-normalising properties, these active ingredients help to counter the formation and development of comedowns (whiteheads and blackheads), reducing the clogging of pilosebaceous follicles. Keeps the proliferation of Cutibacterium acnes under control, preventing the pro-inflammatory effects and biofilm formation it triggers.
Benefits
Azelaic acid: regulates sebum, modulates keratinisation and is bacteriostatic. Works on all the components of acne: counters the inflammatory processes in the follicle, controls the excess of sebum secretion, normalises keratinization, counters the proliferation of Cutibacterium acnes
Retinoid (Hydroxyacolone retinoate): normalises keratinisation & helps to reduce inflammation. Non-photosensitising.
- Glycolic acid: performs a keratolytic action on the keratin clogs in the pilosebaceous ducts, reducing the obstruction of comedowns and countering their evolution into papules and pustules.
How to use
Bionike Aknet Azelike Plus Cream After cleansing skin, apply once a day, preferably in the evening.
Suspending treatment during periods of increased sun exposure and using an adequate sunscreen is recommended.
BIONIKE ACNET AZELIKE Cosmetic gel formulation potentiated by the combination of azelaic acid, a new-generation retinoid (HPR) & α-hydroxy acids. Thanks to their keratolytic, bacteriostatic and sebum-normalising properties, these active ingredients help to counter the formation and development of comedones.
- Country of Origin: Italy
- Brand Name: Bionike
Reviews
Clear filtersThere are no reviews yet.